Welcoming Miriam Sánchez Sáez, the new ESR9 of INTERCEPT-MDS!
We are thrilled to announce and extend a warm welcome to our newest team member, Miriam Sánchez Sáez, who has joined us as the Early Stage Researcher (ESR9) for Project Number 9 within INTERCEPT-MDS.
Miriam officially commenced her journey with us on the 15th of January 2024, bringing her expertise and passion to our collaborative efforts. As ESR9, Miriam will be working under the supervion of Hind Meydouf at the Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus (GSH) in Frankfurt, Germany.
Please join us in welcoming Miriam Sánchez Sáez to our INTERCEPT-MDS family. We look forward to a fruitful collaboration and the exciting discoveries that will undoubtedly arise from her work.